SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and fibre channel storage area networking business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom shares faced volatility after the company reported strong quarterly results and tripled its AI semiconductor revenue, though its fourth-quarter revenue guidance slightly missed analyst expectations. Traders are debating whether the stock's significant long-term AI growth projections for fiscal 2027 and 2028 represent a compelling buying opportunity or an over-leveraged bet on speculative demand from large-scale AI infrastructure customers.

Snowflake, Inc. engages in the provision of cloud data warehousing software. The firm offers Data Cloud, an ecosystem where Snowflake customers, partners, data providers, and data consumers can break down data silos and derive value from data. Its platform supports a range of use cases including data warehousing, data lakes, data engineering, data science, data application development, and data sharing. The cloud-native architecture consists of layers across storage, compute, and cloud services. The storage layer ingests structured and semi-structured data to create a unified data record. The compute layer provides dedicated resources to enable users to access common data sets for many use cases without latency. The cloud services layer optimizes each use case's performance requirements with no administration. The company was founded by Marcin Zukowski, Thierry Cruanes, and Benoit Dageville on July 23, 2012 and is headquartered in Menlo Park, CA.

Snowflake Inc

Snowflake shares are surging after the company reported strong quarterly earnings and raised its full-year guidance, driven by accelerating enterprise AI demand. While many investors are celebrating the growth, the community is divided as skeptics debate whether the rally is sustainable given the company's premium valuation and continued lack of GAAP profitability.

Hewlett Packard Enterprise Co. is a global edge-to-cloud company, which engages in the provision of information technology, technology and enterprise products, solutions, and services. It operates through the following segments: Server, Hybrid Cloud, Intelligent Edge, Financial Services, and Corporate Investments and Other. The Server segment consists of general-purpose servers for multi-workload computing and workload-optimized servers to deliver the performance and value for demanding applications, and integrated systems comprised of software and hardware designed to address high-performance computing and supercomputing, artificial intelligence, data analytics, and transaction processing workloads for government and commercial customers globally. The Hybrid Cloud segment is involved in a variety of cloud-native and hybrid solutions across storage, private cloud, and the infrastructure software-as-a-service space. The Intelligent Edge segment offers wired and wireless local area networks, campus, branch, and data center switching, software-defined wide-area-networks, private and public cellular network software, network security, and associated services that enable secure connectivity for businesses of any size. The Financial Services segment provides investment solutions, such as leasing, financing, IT consumption, utility programs, and asset management services for customers that facilitate technology deployment models and the acquisition of complete IT solutions, including hardware, software, and services from Hewlett Packard Enterprise and others. The Corporate Investments and Other segment includes the Advisory and Professional Services business, which primarily offers consultative-led services, HPE and partner technology expertise and advice, implementation services, as well as complex solution engagement capabilities, the Communications and Media Solutions business, which primarily offers software and related services to the telecommunications industry, and Hewlett Packard Labs, which is responsible for research and development. The company was founded by William R. Hewlett and David Packard on July 2, 1939 and is headquartered in Spring, TX.

Hewlett Packard Enterprise Co

HPE is trending following its fiscal third-quarter results, where the company exceeded analyst expectations for revenue and earnings and raised its future guidance, though investors expressed concerns regarding margin pressure and supply-chain constraints. While some traders view the resulting price decline as an undervaluation opportunity given the company's strong AI-driven networking and hybrid cloud growth, others remain cautious about potential margin deterioration and structural risks.

Ultragenyx Pharmaceutical, Inc. is a biopharmaceutical company, which engages in the identification, acquisition, development, and commercialization of novel products for the treatment of genetic diseases. Its products include Crysvita, Mepsevii, Dojolvi, and Evkeeza. The company was founded by Emil D. Kakkis in April 2010 and is headquartered in Novato, CA.

Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical Inc

Ultragenyx is trading significantly lower after its late-stage study of the experimental Angelman syndrome therapy, GTX-102, failed to meet its primary and secondary endpoints. While some traders view the selloff as an overreaction, pointing to the company's established commercial product portfolio and upcoming regulatory catalysts, many others are expressing concern over the pipeline's growth outlook and the company's future spending plans.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as traders focus on the upcoming Cybercab robotaxi launch in Austin, with sentiment split between excitement over the potential technological breakthrough and skepticism regarding the company's valuation and the actual commercial viability of the fleet. The conversation is further fueled by speculation about a possible surprise announcement or short squeeze, though many participants remain cautious about the event potentially being a 'sell-the-news' catalyst.

Ciena Corp. is a network technology company, which engages in the provision of hardware, software, and services to network operators, as well as enabling enhanced network capacity, service delivery, and automation. It operates through the following segments: Networking Platforms, Platform Software and Services, Blue Planet Automation Software and Services, and Global Services. The Networking Platforms segment consists of converged packet optical and packet networking portfolios. The Platform Software and Services segment provides analytics, data, and planning tools to assist customers in managing its networking platforms products. The Blue Planet Automation Software and Services segment enables customers to implement large-scale software and IT-led OSS transformations by transforming legacy networks into service ready networks. The Global Services segment offers a broad suite of value-added services. The company was founded by Patrick H. Nettles and Kevin Brian Kimberlin in 1992 and is headquartered in Hanover, MD.

CIENA Corp.

Ciena is attracting significant attention as investors react to a beat-and-raise earnings report, with the company raising its fiscal year revenue guidance amid sustained AI-driven demand for its optical networking infrastructure. While some traders are capitalizing on recent volatility and price pullbacks, the broader conversation remains focused on the company's role as a key player in the AI hardware supply chain.

UiPath, Inc. engages in the development and provision of a software platform to automate business processes. The firm serves the public, healthcare, telecommunication, finance, and banking industries. It also offers accounts payable automation, claims processing automation, contact center automation, and finance and accounting automation. The company was founded by Daniel Dines and Marius Tirca in 2005 and is headquartered in New York, NY.

UiPath Inc - Ordinary Shares - Class A

UiPath Inc

UiPath is experiencing strong momentum and heightened market interest as traders anticipate its upcoming earnings report, with many focusing on the company's potential for a short squeeze given its significant short interest. Investors are closely monitoring the stock's performance alongside other enterprise software companies, debating whether its shift into Agentic AI will drive a valuation re-rating.

AeroVironment, Inc. is a defense technology company delivering integrated capabilities across air, land, sea, space, and cyber. The company develops and deploys autonomous systems, loitering munitions, counter-UAS technologies, space-based platforms, directed energy systems, and cyber and electronic warfare capabilities-built to meet the mission needs of today’s warfighter and tomorrow’s conflicts. At the core of these technologies lies AV_Halo, a modular, mission-ready suite of AI-powered software tools that empowers warfighters and enables full-battlefield dominance: detect, decide, deliver. With a national manufacturing footprint and a deep innovation pipeline, AV delivers proven systems and future-defining capabilities at speed, scale, and operational relevance. The company was founded by Paul B. MacCready, Jr. in July 1971 and is headquartered in Arlington, VA.

AeroVironment Inc.

AeroVironment is trending following the announcement of a significant U.S. Army contract for the Locust X3 laser weapon system, which traders view as a major milestone for directed-energy drone defense. While some investors remain frustrated by the stock's recent performance, the contract win and a subsequent analyst upgrade have fueled optimism regarding the company's backlog and growth trajectory in modern defense.

Fluence Energy, Inc. engages in energy storage products and services, and artificial intelligence-enabled digital applications for renewables and storage. Its storage includes Smartstack, Gridstack Pro, Grisdtack, and Ultrastack. The company was founded on June 21, 2021, and is headquartered in Arlington, VA.

Fluence Energy Inc - Ordinary Shares - Class A

Fluence Energy is experiencing significant volatility driven by a major guidance cut and revenue deferral, leading traders to weigh the company's massive $6.4 billion backlog against ongoing execution and margin concerns. While some in the community are accumulating shares at lower prices, betting on the long-term data center and grid-scale storage demand, others remain skeptical, pointing to the company's historically poor margins and serial project delays.

Credo Technology Group Holding Ltd. engages in the development of connectivity solutions and products for the data infrastructure market. Its products include integrated circuits, active electrical cables, and SerDes chiplets. The company was founded by Chi Fung Cheng and Yat Tung Lam on 2008 and is headquartered in George Town, Cayman Islands.

Credo Technology Group Holding Ltd

Credo Technology Group is experiencing sharp volatility and a significant price decline following fiscal first-quarter results that beat expectations but raised concerns regarding margin compression and the pace of optical business expansion. While analysts maintain bullish long-term ratings, the community is divided between those viewing the pullback as an institutional-led manipulation or overreaction providing a buying opportunity, and others warning of further downside due to lofty valuations and market-wide AI sector cooling.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

India Close To Dengue Vaccine: All About The Phase 3 Trials And More

DengiAll, which is Panacea Biotec's tetravalent live-attenuated vaccine, uses weakened strains of all four DENV serotypes. As a single-dose shot, it simplifies administration compared to other multi-dose vaccines.

HC grants interim relief on GST levy on corporate guarantees

The Punjab and Haryana High Court has provided interim relief to Panacea Biotec. The court has stayed any coercive action regarding Goods and Services Tax on corporate guarantees. This applies to guarantees issued before a recent amendment to the CGST Rules. The court is examining the retrospective application of GST.

Indian shares subdued on thin year-end trade

India’s equity benchmarks slipped on Friday as volumes thinned toward the year-end, with analysts saying that an advance depended on momentum from the quarterly earnings season starting next month. The Nifty 50 index fell 0.25% to 26,077.85, while the BSE Sensex index shed 0.26% to 85,186.61, as of 9:54 a.m. IST. Most Asian markets, including India, were closed on Thursday for the Christmas holiday. Twelve of the 16 major sectors logged losses. Both the Nifty and Sensex hit record highs in November after 14 months, but have remained subdued so far in December, shedding about 0.3% and 0.5%, respectively. “We expect Indian equities to trade in a narrow range in the remaining sessions of 2025 due to a lack of triggers and reduced trading activity due to holidays across several global markets,” said Siddhartha Khemka, head of research of wealth management at Motilal Oswal Financial Services. Financial institutions such as banks and investment firms likely indulged in year-end book squaring, a process to close out or rebalance their positions to tidy up books.

Panacea Biotec bags Rs 127 crore order for oral polio vaccines

Panacea Biotec has secured a significant deal to supply bivalent oral polio vaccines valued at Rs 127.2 crore to the Central Medical Services Society. This crucial supply, confirmed via a Letter of Acceptance, will be delivered in multiple phases over 90 to 480 days, bolstering India's ongoing polio eradication efforts.

Hyderabad’s AIIMS Bibinagar leads final trials for India’s first indigenous dengue vaccine

Hyderabad’s AIIMS Bibinagar has emerged as a crucial site for India’s first indigenous dengue vaccine, currently in phase III clinical trials. Led by ICMR and developed in partnership with Panacea Biotec, the single-shot tetravalent vaccine is in its final phase of enrollment.

Phase III clinical trial enrollment for India's first dengue vaccine reaches 70%: The Minister

New Delhi, Aug 1 : The phase III clinical trial for Indias 1st dengue vaccine has enroled 70 per cent participants, said Union Minister of State for Health, Prataprao Jadhav, in the Parliament on Friday. In a written reply to the Lok Sabha, Jadhav shared details on the Phase III clinical trial of the indigenous one-shot dengue vaccine, DengiAll. The trial involves over 10,000 participants, out of which more than 70 per cent enrolment has been completed, Jadhav said. The trial is likely to be completed by October. The trial has been implemented in 20 sites across India. The approximate budget is Rs 1.3 to 1.5 crore per site for the trial, he added. The indigenous tetravalent dengue vaccine, DengiAll, is being developed by Panacea Biotec under a licensing agreement with the National Institutes of Health (NIH). The vaccine targets all four dengue virus subtypes and has shown promising results in earlier clinical trials. As per data from the National Centre for Disease Control (NCDC), a total of 5,73,563 laboratory-confirmed (L form) dengue cases were reported in 2024.

Panacea Biotec Ltd. is a biotechnology company, which engages in the business of research, development, manufacture, and marketing of vaccines and pharmaceutical formulations. It operates through the Vaccines and Formulations segments. Its products cover a range of medical areas such as renal disease management, nephrology, oncology, diabetes management, and pediatric vaccines. The company was founded by Soshil Kumar Jain on February 2, 1984 and is headquartered in New Delhi, India.

Current Price	390.05
Prev Close	384.00
Open	383.80
Dividend Yield	0.00%
50-Day Moving Average	462.47
Beta	N/A
Avg. Volume	147,315.52
PE Ratio	-327.55

52-Week High	647.00
52-Week Low	292.40
Market Capitalization	24B
EPS (Annual)	-0.88
Price to Book	2.83
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info